Singapore REITs Monthly: April24 – Pricing in higher-for-longer interest rates May 20, 2024 416

  • The S-REITs Index fell 3.1% in April after gaining 0.6% in March, following the Fed’s reiteration of its higher-for-longer interest rate stance. The top performer for the month was Cromwell European REIT (CERT SP, BUY, TP €1.91) – it gained 8% in April after the ECB signalled it would likely cut interest rates in June. The worst performer was Prime US REIT (PRIME SP, ACCUMULATE, TP US$0.12), which fell 17.6% as it has yet to refinance its US$480mn loan maturing in July 2024. The Singapore commercial sub-sector was the top performer in April, gaining 1.1% after better-than-expected positive rental reversion in 1Q24. The worst performing sub-sector was overseas commercial, which was down 8.3% in April, dragged by US office REITs as conditions remain challenging.
  • S-REITs are now trading at a forward dividend yield spread of c.3% (-1.5x s.d.) and a P/NAV of 0.86x (-2x s.d.).
  • We remain OVERWEIGHT on S-REITs but are selective. We favour REITs with a healthy balance sheet, strong sponsors, and improving operating metrics, such as REITs in the hospitality and retail sub-sector. Catalysts are expected from a pick-up in the economy, asset recycling, and interest rate cuts. CapitaLand Ascott Trust (CLAS SP, ACCUMULATE, TP S$1.04) and Cromwell European REIT (CERT SP, BUY, TP €1.91) are top picks.

 

SECTOR ROUND-UP

The Fed kept the federal funds rate unchanged at 5.25-5.5% for the sixth straight meeting on 1 May and remains cautious on interest rates cuts this year – it will need to see more positive signs that inflation is moving towards its 2% target. With lower interest rates, S-REITs will benefit from 1) lower financing costs, 2) higher dividend yield spreads over bonds, and 3) higher property valuations as cap rates compress. Furthermore, we expect deal-making to pick up pace with interest rates peaking. Therefore, we expect a sector recovery in 2024-2025.

 

1Q24 performance for S-REITs under over coverage was mostly within expectations, with rental reversions for office and retail coming in above our expectations. We noticed that many S-REITs are divesting non-core assets as part of their deleveraging strategy to lower gearing and strengthen their balance sheet. One example would be Prime US REIT (PRIME SP, ACCUMULATE, US$0.12), which recently divested One Town Center in Boca Raton, Florida, for a price of US$82mn, US$2.8mn below its most recent valuation. We think this divestment trend will continue into 2024-2025 as the transactions market gradually gains momentum.

 

Retail

1Q24 rental reversions exceeded our expectations. Frasers Centrepoint Trust (FCT SP, ACCUMULATE, TP S$2.38), CapitaLand Integrated Commercial Trust (CICT SP, non-rated), and Lendlease Global Commercial REIT (LREIT SP, BUY, TP S$0.83) had suburban mall rental reversions of above 7%. Suntec REIT’s (SUN SP, BUY, TP S$1.41) Suntec City Mall had rental reversions of +21.7%. Landlords noted that tenants are willing to pay higher rent as the outlook for tenant sales is strong. New demand is coming from Chinese, Korean, and Japanese brands expanding into Singapore. This is especially true for Chinese F & B brands as those brands see a lack of growth potential in China and seek to expand overseas.  

The Marcg 24 retail sales index (excluding motor vehicles) rose 2% YoY, extending the 9.5% growth in February 24. Most industries recorded YoY growth, with the food & alcohol and watches & jewellery industries outperforming at +17% and +14.1% YoY, respectively. Computer & telecommunications equipment was the biggest decliner, recording a 5.1% drop in sales YoY in Mar 24.

The F&B services index rose 5% YoY in March 24, extending the 14.8% growth in February 24. Food caterers and restaurants registered 13.5% and 7.1% sales growth, respectively. We think retail sales will remain resilient in 2024, boosted by the various government handouts.

Hospitality

1Q24 RevPAR continued to improve for REITs under our coverage. CapitaLand Ascott Trust (CLAS SP, ACCUMULATE, TP S$1.04) had portfolio RevPAR growth of 6% YoY, in line with pre-COVID RevPAR. Far East Hospitality Trust (FEHT SP, BUY, S$0.79) had hotel RevPAR increase 6.7% YoY, reaching 102.9% of pre-COVID levels.

 

Singapore’s international visitor arrivals grew 20% YoY in April 24 to 1.35mn, and they are 15% below pre-COVID levels (Figure 8). Visitor arrivals from China grew 2.4 times in April 24 and are now 27% below pre-COVID levels after the 30-day visa-free entry for Chinese citizens rolled out on 9 February 24.

 

RevPAR continued to grow (+20.5% YoY) in March 24 after gaining 7.6% YoY in February 24, supported by higher average daily room rates (+14.3% YoY) and occupancy (+4.4%pts). RevPAR was boosted by the Taylor Swift Eras Tour, which saw huge foreign demand. We think RevPAR will continue its growth trajectory in 2024 with a solid concert line-up and a packed MICE schedule in Singapore.

 

Office

Rental reversions for 1Q24 were better than we expected. CapitaLand Integrated Commercial Trust (CICT SP, non-rated) had a positive rental reversion of 14.1% for its office portfolio. Keppel REIT (KREIT SP, non-rated) and Suntec REIT’s (SUN SP, BUY, TP S$1.41) Singapore office portfolio had positive reversions of 10.9% and 11.4%, respectively. Tenant retention is high as tenants are unwilling to spend capex for new premises. However, demand for new space is largely only from smaller tenants.

 

Industrial

Logistics continues to be the star performer for industrial REITs, while business parks remain the laggard. This is except for China, where logistics is still expected to remain weak for the next few quarters due to 1) an influx of new supply into the market, 2) an increase in tenant incentives, and 3) subdued economic activity.

Important Information

This report is prepared and/or distributed by Phillip Securities Research Pte Ltd ("Phillip Securities Research"), which is a holder of a financial adviser’s licence under the Financial Advisers Act, Chapter 110 in Singapore.

By receiving or reading this report, you agree to be bound by the terms and limitations set out below. Any failure to comply with these terms and limitations may constitute a violation of law. This report has been provided to you for personal use only and shall not be reproduced, distributed or published by you in whole or in part, for any purpose. If you have received this report by mistake, please delete or destroy it, and notify the sender immediately.

The information and any analysis, forecasts, projections, expectations and opinions (collectively, the “Research”) contained in this report has been obtained from public sources which Phillip Securities Research believes to be reliable. However, Phillip Securities Research does not make any representation or warranty, express or implied that such information or Research is accurate, complete or appropriate or should be relied upon as such. Any such information or Research contained in this report is subject to change, and Phillip Securities Research shall not have any responsibility to maintain or update the information or Research made available or to supply any corrections, updates or releases in connection therewith.

Any opinions, forecasts, assumptions, estimates, valuations and prices contained in this report are as of the date indicated and are subject to change at any time without prior notice. Past performance of any product referred to in this report is not indicative of future results.

This report does not constitute, and should not be used as a substitute for, tax, legal or investment advice. This report should not be relied upon exclusively or as authoritative, without further being subject to the recipient’s own independent verification and exercise of judgment. The fact that this report has been made available constitutes neither a recommendation to enter into a particular transaction, nor a representation that any product described in this report is suitable or appropriate for the recipient. Recipients should be aware that many of the products, which may be described in this report involve significant risks and may not be suitable for all investors, and that any decision to enter into transactions involving such products should not be made, unless all such risks are understood and an independent determination has been made that such transactions would be appropriate. Any discussion of the risks contained herein with respect to any product should not be considered to be a disclosure of all risks or a complete discussion of such risks.

Nothing in this report shall be construed to be an offer or solicitation for the purchase or sale of any product. Any decision to purchase any product mentioned in this report should take into account existing public information, including any registered prospectus in respect of such product.

Phillip Securities Research, or persons associated with or connected to Phillip Securities Research, including but not limited to its officers, directors, employees or persons involved in the issuance of this report, may provide an array of financial services to a large number of corporations in Singapore and worldwide, including but not limited to commercial / investment banking activities (including sponsorship, financial advisory or underwriting activities), brokerage or securities trading activities. Phillip Securities Research, or persons associated with or connected to Phillip Securities Research, including but not limited to its officers, directors, employees or persons involved in the issuance of this report, may have participated in or invested in transactions with the issuer(s) of the securities mentioned in this report, and may have performed services for or solicited business from such issuers. Additionally, Phillip Securities Research, or persons associated with or connected to Phillip Securities Research, including but not limited to its officers, directors, employees or persons involved in the issuance of this report, may have provided advice or investment services to such companies and investments or related investments, as may be mentioned in this report.

Phillip Securities Research or persons associated with or connected to Phillip Securities Research, including but not limited to its officers, directors, employees or persons involved in the issuance of this report may, from time to time maintain a long or short position in securities referred to herein, or in related futures or options, purchase or sell, make a market in, or engage in any other transaction involving such securities, and earn brokerage or other compensation in respect of the foregoing. Investments will be denominated in various currencies including US dollars and Euro and thus will be subject to any fluctuation in exchange rates between US dollars and Euro or foreign currencies and the currency of your own jurisdiction. Such fluctuations may have an adverse effect on the value, price or income return of the investment.

To the extent permitted by law, Phillip Securities Research, or persons associated with or connected to Phillip Securities Research, including but not limited to its officers, directors, employees or persons involved in the issuance of this report, may at any time engage in any of the above activities as set out above or otherwise hold an interest, whether material or not, in respect of companies and investments or related investments, which may be mentioned in this report. Accordingly, information may be available to Phillip Securities Research, or persons associated with or connected to Phillip Securities Research, including but not limited to its officers, directors, employees or persons involved in the issuance of this report, which is not reflected in this report, and Phillip Securities Research, or persons associated with or connected to Phillip Securities Research, including but not limited to its officers, directors, employees or persons involved in the issuance of this report, may, to the extent permitted by law, have acted upon or used the information prior to or immediately following its publication. Phillip Securities Research, or persons associated with or connected to Phillip Securities Research, including but not limited its officers, directors, employees or persons involved in the issuance of this report, may have issued other material that is inconsistent with, or reach different conclusions from, the contents of this report.

The information, tools and material presented herein are not directed, intended for distribution to or use by, any person or entity in any jurisdiction or country where such distribution, publication, availability or use would be contrary to the applicable law or regulation or which would subject Phillip Securities Research to any registration or licensing or other requirement, or penalty for contravention of such requirements within such jurisdiction.

This report is intended for general circulation only and does not take into account the specific investment objectives, financial situation or particular needs of any particular person. The products mentioned in this report may not be suitable for all investors and a person receiving or reading this report should seek advice from a professional and financial adviser regarding the legal, business, financial, tax and other aspects including the suitability of such products, taking into account the specific investment objectives, financial situation or particular needs of that person, before making a commitment to invest in any of such products.

This report is not intended for distribution, publication to or use by any person in any jurisdiction outside of Singapore or any other jurisdiction as Phillip Securities Research may determine in its absolute discretion.

IMPORTANT DISCLOSURES FOR INCLUDED RESEARCH ANALYSES OR REPORTS OF FOREIGN RESEARCH HOUSE

Where the report contains research analyses or reports from a foreign research house, please note:

  1. recipients of the analyses or reports are to contact Phillip Securities Research (and not the relevant foreign research house) in Singapore at 250 North Bridge Road, #06-00 Raffles City Tower, Singapore 179101, telephone number +65 6533 6001, in respect of any matters arising from, or in connection with, the analyses or reports; and
  2. to the extent that the analyses or reports are delivered to and intended to be received by any person in Singapore who is not an accredited investor, expert investor or institutional investor, Phillip Securities Research accepts legal responsibility for the contents of the analyses or reports.
Subscribe
Notify of
guest
0 Comments
Inline Feedbacks
View all comments

Get access to all the latest market news, reports, technical analysis
by signing up for a free account today!